These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6391745)
1. Effect of sodium salicylate on hormonal responses to hypoglycaemia in type II diabetics. Brass EP; Halter JB; Ensinck JW; Robertson RP Clin Endocrinol (Oxf); 1984 Dec; 21(6):649-55. PubMed ID: 6391745 [TBL] [Abstract][Full Text] [Related]
2. Effects of acute sodium salicylate on the abnormal counterregulatory glucagon and epinephrine responses to insulin hypoglycemia in diabetic rats. Patel DG Life Sci; 1989; 44(4):301-10. PubMed ID: 2644509 [TBL] [Abstract][Full Text] [Related]
3. Effects of chronic sodium salicylate feeding on the impaired glucagon and epinephrine responses to insulin-induced hypoglycaemia in streptozotocin diabetic rats. Patel DG; Skau KA Diabetologia; 1989 Jan; 32(1):61-6. PubMed ID: 2707517 [TBL] [Abstract][Full Text] [Related]
4. Normalization by sodium salicylate of the impaired counterregulatory glucagon response to hypoglycemia in insulin-dependent diabetes. A possible role for endogenous prostaglandins. Giugliano D; Giannetti G; Di Pinto P; Cerciello T; Ceriello A; D'Onofrio F Diabetes; 1985 Jun; 34(6):521-5. PubMed ID: 3891465 [TBL] [Abstract][Full Text] [Related]
5. Counterregulatory hormonal responses to hypoglycaemia in type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion. Frier BM; Fisher BM; Gray CE; Beastall GH Diabetologia; 1988 Jul; 31(7):421-9. PubMed ID: 2851469 [TBL] [Abstract][Full Text] [Related]
6. [Effect of sodium salicylate on insulin secretion and blood glucose behavior in metabolically healthy and type II diabetic patients]. Wünsch C; Lohmann D; Verlohren HJ Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):317-24. PubMed ID: 3912157 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin synthesis inhibitors impair hepatic glucose production in response to glucagon and epinephrine stimulation. Miller JD; Ganguli S; Sperling MA Diabetes; 1983 May; 32(5):439-44. PubMed ID: 6301913 [TBL] [Abstract][Full Text] [Related]
8. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors. Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039 [TBL] [Abstract][Full Text] [Related]
9. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes. Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114 [TBL] [Abstract][Full Text] [Related]
10. Saxagliptin co-therapy in C-peptide negative Type 1 diabetes does not improve counter-regulatory responses to hypoglycaemia. George PS; McCrimmon RJ Diabet Med; 2016 Sep; 33(9):1283-90. PubMed ID: 26642301 [TBL] [Abstract][Full Text] [Related]
12. Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus. Hompesch M; Jones-Leone A; Carr MC; Matthews J; Zhi H; Young M; Morrow L; Reinhardt RR Diabetes Obes Metab; 2015 Jan; 17(1):82-90. PubMed ID: 25263215 [TBL] [Abstract][Full Text] [Related]
13. A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man. Liu D; Moberg E; Kollind M; Lins PE; Adamson U J Clin Endocrinol Metab; 1991 Nov; 73(5):1123-8. PubMed ID: 1682339 [TBL] [Abstract][Full Text] [Related]
14. Response of pancreatic polypeptide to hypoglycaemia in insulin-dependent diabetics with and without residual beta-cell function. Krarup T; Madsbad S; Hilsted J; Christensen NJ; Sestoft L; Schwartz TW Clin Endocrinol (Oxf); 1983 Jan; 18(1):31-6. PubMed ID: 6342858 [TBL] [Abstract][Full Text] [Related]
15. The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus. Kennedy FP; Bolli GB; Go VL; Cryer PE; Gerich JE J Clin Endocrinol Metab; 1987 Mar; 64(3):602-8. PubMed ID: 3818892 [TBL] [Abstract][Full Text] [Related]
16. Direct quantification of norepinephrine spillover and hormone output from the pancreas of the conscious dog. Dunning BE; Scott MF; Neal DW; Cherrington AD Am J Physiol; 1997 May; 272(5 Pt 1):E746-55. PubMed ID: 9176171 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin synthesis inhibitors reverse alpha-adrenergic inhibition of acute insulin response to glucose. Metz SA; Robertson RP Am J Physiol; 1980 Dec; 239(6):E490-500. PubMed ID: 6255805 [TBL] [Abstract][Full Text] [Related]
18. Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes. Spyer G; Hattersley AT; MacDonald IA; Amiel S; MacLeod KM Lancet; 2000 Dec; 356(9246):1970-4. PubMed ID: 11130525 [TBL] [Abstract][Full Text] [Related]
19. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans. Christensen MB Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187 [TBL] [Abstract][Full Text] [Related]
20. Muscarinic cholinergic antagonism does not enhance recovery from hypoglycemia in IDDM. Hvidberg A; Cryer PE Diabetes Care; 1995 Mar; 18(3):404-7. PubMed ID: 7555487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]